PPD – Part of Thermo Fisher Scientific
The PPD clinical research business of Thermo Fisher Scientific enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centred strategies and data analytics, our capabilities include extensive experience in respiratory research, with a strong focus on interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF). Our services span early development, all phases of clinical development, peri- and post-approval, innovative patient recruitment and investigator site solutions, and comprehensive laboratory services.
